Skip to main content
Log in

Synthese und Antitumoraktivität voncis-Dichloroplatin(II)-Komplexen mit Östradiolderivaten

Synthesis and antitumor activity of Pt(II) complexes of estradiol derivatives

  • Organische Chemie Und Bicchemie
  • Published:
Monatshefte für Chemie / Chemical Monthly Aims and scope Submit manuscript

Summary

Estrogen-receptor binding moieties were introduced into Pt(II) complexes in order to facilitate the selective transport into cancer cells. Estradiol esters of 2,3-diaminopropionic acid and estradiol ethers of 1,2-diamino-2-methyl-3-(p-hydroxyphenyl)propane were attached to Pt(II) complexes. The antitumor activity of the compounds was tested towards the human mammary carcinoma cell lines MDA-MB 231 and MCF-7, respectively, and the estrogen-receptor binding affinity of the Pt(II) complexes was determined. The steroidal Pt(II) complexes gave a maximum growth inhibition of 80% and a maximum estrogen-receptor binding affinity of 5.18.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Literatur

  1. Lippman M. E. (1976) Breast Cancer: Trends in Research and Treatment. Heuson J. C., Raven Press, New York

    Google Scholar 

  2. Maas H. (1977) Gynäkologie10: 183

    Google Scholar 

  3. Brodie A. M. H. (1982) Cancer Res.42: 3312

    Google Scholar 

  4. Corbin A. (1982) J. Biol. Med.55: 27

    Google Scholar 

  5. Rocheford H., Westley B. (1984) Biochem. Action Horm.11: 241

    Google Scholar 

  6. Morck H. (1989) Pharmazeutische Zeitung8: 9

    Google Scholar 

  7. Keppler B. K. (1990) New J. Chem.14: 389

    Google Scholar 

  8. Leclercq G., Heuson J. C. (1981) Anticancer Res.1: 217

    Google Scholar 

  9. Schapira D. (1978) Cancer Clin. Trials1: 5

    Google Scholar 

  10. EORTC Breast Cancer Cooperative Group (1969) Eur. J. Cancer5: 1

    Google Scholar 

  11. Schönemann K. H. (1980) Eur. J. Med. Chem. Chim. Ther.15: 333

    Google Scholar 

  12. Lam H. (1980) J. Med. Chem.22: 200

    Google Scholar 

  13. Leclercq G. (1980) Breast Cancer. Experimental and Clinical Aspects. Mouridsen H. T., Palshof T., Pergamon Press, Oxford, S. 287

    Google Scholar 

  14. Blickenstaff R. P., Gerzon K. (1980) Cytotoxic estrogens in hormon receptive tumors. Raus J., Academic Press, London, S. 89

    Google Scholar 

  15. Katzenellenbogen J. A. (1975) Biochemistry14: 1742

    Google Scholar 

  16. Seitz D. E. (1980) J. Organomet. Chem.186: C33

    Google Scholar 

  17. Hochberg R. B., Rosner W. (1980) Proc. Natl. Acad. Sci. (USA)77: 328

    Google Scholar 

  18. Katzenellenbogen J. A. (1980) J. Nucl. Med.21: 550

    Google Scholar 

  19. Hartmann W. R. (1989) Pharmazeutische Zeitung43: 9

    Google Scholar 

  20. Hochberg R. B. (1980) Cytotoxic estrogens in hormon receptive tumors. Raus J., Academic Press, London, S. 123

    Google Scholar 

  21. Ostrow S., Egorin M., Aisner J., Bachur N., Wiernik P. H. (1980) Cancer Clin. Trials3: 23

    Google Scholar 

  22. Forastiere A. A., Hakes T. B., Wittes J. T., Wittes R. E. (1982) Am. J. Clin. Oncol.6: 243

    Google Scholar 

  23. Schönenberger H., Wappes B., Jennerwein M., Berger M. R. (1984) Cancer Treat. Rev. Suppl. A11: 125

    Google Scholar 

  24. Wappes B., Jennerwein M., v. Angerer E., Schönenberger H., Engel J., Berger M. R., Wrobel K. H. (1984) J. Med. Chem.27: 1280

    Google Scholar 

  25. Wappes B., Jennerwein M., v. Angerer E., Engel J., Schönenberger H., Brunner H., Schmidt M., Berger M. R., Schmähl D., Seeber S. (1984) J. Cancer Res. Clin. Oncol.107: 15

    Google Scholar 

  26. Schönenberger H., Wappes B., Jennerwein M., Berger M. (1984) Contrib. Oncol.18: 48

    Google Scholar 

  27. Brunner H., Dafinger W., Schönenberger H. (1989) Inorg. Chim. Acta156: 291

    Google Scholar 

  28. v. Angerer E., Prekajac J., Berger M. (1985) Eur. J. Cancer Clin. Oncol.21: 532

    Google Scholar 

  29. Knebel N., v. Angerer E. (1988) J. Med. Chem.31: 1675

    Google Scholar 

  30. McGuire W. L. (1980) Hormones and Cancer. Iacobelli S., Raven Press, New York

    Google Scholar 

  31. Peridaens R. J., Rederc G., Heuson J. C. (1983) Cancer Chemotherapy. Pinedeo H. M., Chabner B. A., Elsevier, Amsterdam

    Google Scholar 

  32. Gandolfi O., Cais M., Dolcetti G., Gedini M., Modiano A. (1981) Inorg. Chim. Acta56: 127

    Google Scholar 

  33. Gandolfi O., Blum J., Mandelbaum-Shavit F. (1984) Inorg. Chim. Acta91: 257

    Google Scholar 

  34. Fernandez G. J. M., Rubio-Arroyo M. F., Rubio-Poo C., de la Pena A. (1983) Monatsh. Chem.114: 535

    Google Scholar 

  35. Georgiadis M. P., Haroutounian S. A., Chondros K. P. (1987) Inorg. Chim. Acta138: 249

    Google Scholar 

  36. Kidani Y. (1989) Eur. Pat. 0 265 350 A1 (CA 110: 32970x)

  37. Gandolfi O., Apfelbaum H., Migron Y. (1989) Inorg. Chim. Acta161: 113

    Google Scholar 

  38. Ehrenstorfer-Schäfer E. M., Altman J. M., Steiner N., Beck W. (1990) Z. Naturforsch.45: 817

    Google Scholar 

  39. Altman J., Castrillo T., Beck W., Bernhardt G., Schönenberger H. (1991) Inorg. Chem.30: 4085

    Google Scholar 

  40. Brunner H., Maiterth F., Treittinger B. (1992) Z. Naturforsch.476: 942

    Google Scholar 

  41. Müller E. (1974) Methoden der organischen Chemie (Houben-Weyl). Thieme Stuttgart, Band 15 I, S. 117

    Google Scholar 

  42. Regnarsson U., Karlsson S., Lindeberg G. (1970) Acta Chem. Scand.24: 2821

    Google Scholar 

  43. Breitmaier E., Jung G. (1986) Organische Chemie I. Thieme Verlag, Stuttgart, 2. Aufl., S. 474

    Google Scholar 

  44. Dean P. D. G., Exley D., Johnson M. W. (1971) Steroids18: 593

    Google Scholar 

  45. Brunner H., Obermann U. (1989) Chem. Ber.122: 499

    Google Scholar 

  46. Blickenstaff R. T., Foster E., Gerzon K., Young P. (1985) Steroids46: 889

    Google Scholar 

  47. Biel J. H. (1951) J. Am. Chem. Soc.73: 847

    Google Scholar 

  48. Lapatsanis L., Profillis C., Catsoulacos P. (1980) J. Chem. Eng. Data25: 287

    Google Scholar 

  49. Staab H. A. (1962) Angew. Chem.74: 407

    Google Scholar 

  50. Guttmann S., Boissonas R. A. (1958) Helv. Chim. Acta41: 1852

    Google Scholar 

  51. Heatcock C. H., Ratcliffe R. (1971) J. Am. Chem. Soc.93: 1746

    Google Scholar 

  52. Brunner H., Hankofer P., Treittinger B. (1990) Chem. Ber.123: 1029

    Google Scholar 

  53. Földi Z. (1920) Ber. Dtsch. Chem. Ges.53: 1839

    Google Scholar 

  54. Greene T. W. (1981) Protective Groups in Organic Synthesis. Wiley, New York, S. 324

    Google Scholar 

  55. Müller E. (1974) Methoden der organischen Chemie (Houben-Weyl). Thieme Stuttgart, Band 15 I, S. 129

    Google Scholar 

  56. Streitwieser A., Heatcock C. H. (1980) Organische Chemie. Verlag Chemie, Weinheim, S. 291

    Google Scholar 

  57. Sperl G. (1992) Dissertation, Universität Regensburg

  58. Bhacca N. S., Hollis D. P., Johnson L. F., Pier E. A., Shooley J. N. (1962/63) High resolution NMR spectra catalog. Varian Associates, lithographed in the USA by the National Press, Nr. 9946M/1357M/9984M

  59. Siegel M. M., Bitha P., Child R. G., Hlavka J. J., Lin Y.-I. (1986) Biomedical and Environmental Mass Spectrometry13: 25

    Google Scholar 

  60. Madeddu L., Roy F., Leclercq G. (1986) Anticancer Res.6: 11

    Google Scholar 

  61. Gillies R. J., Didiers N., Denton M. (1986) Analyt. Biochem.159: 109

    Google Scholar 

  62. Cailleau R., Young R., Olive M., Reeves W. R. (1974) J. Nat. Canc. Inst.53: 661

    Google Scholar 

  63. Hartmann R. W. (1984) Cancer Treat. Rev. Suppl. A11: 155

    Google Scholar 

  64. Korenman S. G. (1986) J. Clin. Endocrin. Metab.28: 127

    Google Scholar 

  65. EORTC Breast Cancer Cooperative Group (1973) Eur. J. Cancer9: 379

    Google Scholar 

  66. Birnböck H., Ringshandl R., v. Angerer E. (1987) J. Chromatogr.414: 235

    Google Scholar 

  67. Schüler F. W. (1946) Science103: 221

    Google Scholar 

  68. Zeelen F. J., Bergink E. W. (1980) Cytostatic Estrogens in Hormon Receptive Tumors. Raus J., Academic Press, London, S. 40

    Google Scholar 

  69. Leclercq G. (1976) Int. J. Cancer18: 750

    Google Scholar 

  70. Raynaud J. P., Ojasoo T., Bouton M. M., Philibert D. (1979) Drug Design: Chapter 4: Receptor Binding as a Tool in the Development of New Bioactive Steroid, Vol. 8, Ariens E. I., Academic Press, New York, S. 169

    Google Scholar 

  71. Hähnel R., Twaddle E., Ratajczak T. (1973) J. Steroid Biochem.4: 21

    Google Scholar 

  72. Korenman S. G. (1969) Steroids13: 163

    Google Scholar 

  73. Shutt D. A.; Cox R. I. (1972) J. Endocrinol.52: 299

    Google Scholar 

  74. Inagaki K., Kidani Y., Suzuki K., Tashiro T. (1980) Chem. Pharm. Bull.28: 2286

    Google Scholar 

  75. Nambara T., Numazawa M., Takahashi H. (1969) Chem. Pharm. Bull.17: 1725

    Google Scholar 

  76. Marshall D. E., Gower D. B., Houzghton E., Dumasia M. C. (1989) Biochem. Soc. Trans.17: 1018

    Google Scholar 

  77. Allais A., Hoffmann C. (1958) U. S. Patent 2 835 681 (CA 52:P 18531b)

  78. Brunner H., Brandl P. (1991) Tetrahedron: Asymmetry2: 919

    Google Scholar 

  79. Hünig S., Märkl G., Sauer J. (1979) Integriertes organisches Praktikum. Verlag Chemie, Weinheim, S. 547

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brunner, H., Sperl, G. Synthese und Antitumoraktivität voncis-Dichloroplatin(II)-Komplexen mit Östradiolderivaten. Monatsh Chem 124, 83–102 (1993). https://doi.org/10.1007/BF00808513

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00808513

Keywords

Navigation